F-star market cap

Market Cap (MIL) 75.01: Forward P/E-5.91: Dividend (Yield %)--Advanced Charting. Next Event. Spring Bank Pharmaceuticals Inc Annual Shareholders Meeting. F-Star Therapeutics, Inc., formerly

From our deli, bakery, fresh produce and helpful pharmacy staff, we've got you covered! Our bakery features customizable cakes, cupcakes and more while the deli offers a variety of party trays, made to order. On a rolling basis, stocks which come in top 80% of total market-cap are considered largecaps, next 15% midcaps and remaining 5% smallcaps. (Total m-cap classification is done on a daily basis). The company's market cap stands at $787.0 million. F-star Therapeutics (NASDAQ:FSTX) stock decreased by 12.87% to $8.6.

12.12.2020

Spring Bank has been re-named F-star Therapeutics, Inc. and will commence trading on the Nasdaq Capital Market on November 23, 2020 under the ticker symbol "FSTX." F-star Therapeutics, Inc. Common Stock (FSTX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global Market Cap, 66,758,276. 3 Jan 2021 Find the latest F-star Therapeutics, Inc. (FSTX) stock quote, history, Trade prices are not sourced from all markets Market Cap, 76.464M. Name: F-star Therapeutics, Inc. · Ticker: FSTX · Exchange: NasdaqCM · Founded: · Industry: Biotechnology · Sector: Pharmaceuticals & Biotech · Market Cap: US Stockopedia rates F-Star Therapeutics Inc as a Speculative Style Neutral . 1 brokers rate it as a 'Strong Buy'. Market Cap, £46.5m. Enterprise Value, £32.1m . Open $8.30 · Day Range 7.71 - 8.40 · 52 Week Range 3.20 - 12.20 · Market Cap $76.46M · Shares Outstanding 4.32M · Public Float 6.36M · Beta 0.69 · Rev. per Stock analysis for F-star Therapeutics Inc (FSTX:NASDAQ CM) including Market Closed.

F-star Therapeutics Inc is a clinical-stage biopharmaceutical company developing tetravalent bispecific antibodies for a paradigm-shift in cancer therapy. By developing medicines that seek to block tumor immune evasion, the company's goal is to offer patients greater and more durable benefits than immuno-oncology treatments.

The Company is engaged in the discovery and development of a class of therapeutics for the treatment of vir al infections, inflammatory diseases and cancers using its small molecule nucleotide platform. Market Cap. US$106.4m.

Nov 20, 2020

Volume, 0. Day high, 9.2. Day low, 0.999.

Day Range FSTX | Complete F-star Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. F-star Therapeutics has a market capitalization of $30.61 million.

1 brokers rate it as a 'Strong Buy'. Market Cap, £46.5m. Enterprise Value, £32.1m . Open $8.30 · Day Range 7.71 - 8.40 · 52 Week Range 3.20 - 12.20 · Market Cap $76.46M · Shares Outstanding 4.32M · Public Float 6.36M · Beta 0.69 · Rev. per Stock analysis for F-star Therapeutics Inc (FSTX:NASDAQ CM) including Market Closed. As of 03/08/2021 EDT. Open. 7.86.

The company earns $-24,100,000.00 in net income (profit) each year or ($5.88) on an earnings per share basis. How many employees does F-star Therapeutics have? FSTX | Complete F-star Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Dec 31, 2012 Nov 20, 2020 F-star Therapeutics, Inc. Common Stock, also called F-star Therapeutics, is a clinical-stage immuno-oncology company. Read More It focuses on transforming the lives of patients with cancer through the development of tetravalent mAb2 bispecific antibodies.

Day high, 9.2. Day low, 0.999. Year high, 9.2. Year low, 0.868. Year to date change, -36.09%.

Stock analysis for F-star Therapeutics Inc (SBPH) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Market Cap--1D 1M 1Y 5Y. View Full Chart Stock analysis for F-star Therapeutics Inc (FSTX:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Market Cap. 63.446M. Day Range View the latest F-star Therapeutics Inc. (FSTX) stock price, news, historical charts, Market Capitalization Reflects the total market value of a company. Market Cap is calculated by Market Cap. 30.20M.

kde si mozem kupit zapzyt
upgrade dokončený 2 hacknutý odblokovaný
prečo má bitcoin práve teraz takú hodnotu
nájdi môj stratený účet na instagrame
hraničné hodnoty trhového stropu spoločnosti morningstar

Find the latest F-star Therapeutics, Inc. (FSTX) stock quote, history, news and other vital information to help you with your stock trading and investing.

F-star Therapeutics Inc., formerly known as Spring Bank Pharmaceuticals Inc., is based in Nov 20, 2020 Mar 04, 2021 Get the latest F-Star Therapeutics Inc (FSTX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. A high-level overview of F-star Therapeutics, Inc. (FSTX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. F-Star Therapeutics Market Capitalization vs Invested Capital relationship and correlation analysis over time. F-star Therapeutics, Inc. is a clinical-stage immuno-oncology company. It focuses on transforming the lives of patients with cancer through the development of tetravalent mAb2 bispecific antibodies.